| Name | | |
| Last NAV | 31.93 | 67.50 |
| Date of Valuation | 2019/11/11 | 2019/11/11 |
| Sharpe Ratio | N/A | 0.51 |
| 3-Year Risk Return Ratio | 0.16 | 0.83 |
| Cumulative Performance (%) |
| +14.40% | +8.21% |
| +5.34% | +15.50% |
| +7.51% | +11.92% |
| +20.58% | +28.79% |
| -16.31% | -26.80% |
| -17.87% | +14.50% |
| +34.70% | +3.80% |
| +219.30% | +575.00% |
| Calendar Year Performance (%) |
| -16.31% | -26.80% |
| +16.93% | +48.40% |
| -17.87% | +14.50% |
| +4.93% | +1.10% |
| +34.70% | +3.80% |
| 3-Year Annualised Volatility | 16.27% | 14.36% |
| Funds House | Franklin Templeton Investments (Asia) Ltd | J.P. Morgan Asset Management |
| Portfolio Manager | Evan McCulloch & Wendy Lam & Steve Kornfeld | Oliver Cox & Joanna Kwok (Hong Kong) |
| Funds Type | Equity Funds | Equity Funds |
| Funds Size | USD 1620000000 | USD 136000000 |
| Base Currency | USD | USD |
| Sector | Biotechnology | Technology |
| Geographic Allocation | US | Asia (including Japan) |
| Top Holdings |
| ALEXION PHARMACEUTICALS INC (4.31%) | Samsung Electronics Co., Ltd. (8.50%) |
| AMGEN INC (7.74%) | Alibaba Group Holding Ltd. (9.30%) |
| VERTEX PHARMACEUTICALS INC (6.08%) | Keyence Corporation (7.20%) |
| BIOGEN INC (4.11%) | Taiwan Semiconductor Manufacturing Co., Ltd. (9.70%) |
| ILLUMINA INC (4.93%) | Tencent Holdings Ltd. (8.70%) |
| GW PHARMACEUTICALS PLC (3.24%) | |
| REGENERON PHARMACEUTICALS INC (3.07%) | |
| BIOMARIN PHARMACEUTICAL INC (3.00%) | |
| IOVANCE BIOTHERAPEUTICS INC (3.38%) | |
| GILEAD SCIENCES INC (5.34%) | |
| Minimum Initial Investment | USD 1000 | USD 1000 |
| Initial Sales Fee | Class A: Up to 5.00%. Class B: Nil | 5.0% of NAV |
| Switching Fee | Class A: 1.00%. Class B: Nil | 1.0% of NAV |
| Maintenance Fee | Custodian fee Class A: Up to 0.14% ( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Custodian fee Class B: Up to 0.14%( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Maintenance charge Class A: Up to 0.50%. Maintenance charge Class B: Up to 0.75%. Servicing charge Class A: Nil. Servicing charge Class B: 1.06%. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class A: Up to 0.2175%, Up to USD 30 per annum. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class B: Up to 0.2175%, Up to USD 30 per annum. | Trustee fee:0.03%–0.125% of NAV p.a. (maximum 0.2%; subject to the NAV and a minimum of USD 12,500 p.a.) |
| Redemption Fee | Class A: Nil. Class B: Up to 4.00% | 0.5% of NAV |
| Launch Date | 2000/04/03 | 1997/08/15 |
| End of Financial Year | 30/06 | 30/09 |
| Country of Registry | Luxembourg | Hong Kong |
| Other Relevant Information | | |
| |
